Stimulation of the STING pathway has the capacity to bolster host defenses against infectious agents, facilitate tumor suppression, and potentially provide clinical advantages for individuals battling viral hepatitis and advanced-stage HCC. The gene discussed is STING1; the disease is viral hepatitis.